Centrient Pharmaceuticals Netherlands B.V.
Records under this name other than the patents Centrient Pharmaceuticals Netherlands B.V. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.
Showing 1 to 4 of 4 · Back to Centrient Pharmaceuticals Netherlands B.V.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,828,411 | Method for isolating caspofungin Lapsed on the fee record Ended Nov 28, 2025 · USPTO record | Lapsed on the fee record | Ended Nov 28, 2025 | USPTO record |
| US 9,556,233 | Cyclohexapeptide Lapsed on the fee record Ended Jan 31, 2025 · USPTO record | Lapsed on the fee record | Ended Jan 31, 2025 | USPTO record |
| US 9,676,729 | Amine salts of pitavastatin and rosuvastatin Lapsed on the fee record Ended Jun 13, 2021 · USPTO record | Lapsed on the fee record | Ended Jun 13, 2021 | USPTO record |
| US 9,630,906 | Amine salts of pitavastatin and rosuvastatin Lapsed on the fee record Ended Apr 25, 2021 · USPTO record | Lapsed on the fee record | Ended Apr 25, 2021 | USPTO record |